Related Experiment Video
Updated: Jun 6, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Managing invasive fungal disease in immunocompromised patients
1Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium. johan.maertens@uz.kuleuven.ac.be
Abstract:
Celebrating its 30th anniversary in Budapest this year, the International Immunocompromised Host Society (ICHS) was established to advance the understanding of interactions between host defenses and microbial agents in order to improve the prevention and management of human disease in patients with compromised immune function. Much has been achieved in the intervening years, and presentations on the challenges of invasive fungal disease at this year's ICHS congress reflected the changing nature of the population at risk of fungal disease, the growing range of fungal pathogens, and evolving approaches to the prevention, diagnosis and treatment of fungal infection.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Fungal Phylum Microsporidia
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management